Literature DB >> 23747252

Mitochondrial Ca²⁺ uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels.

Giulietta Di Benedetto1, Elisa Scalzotto, Marco Mongillo, Tullio Pozzan.   

Abstract

While the role of mitochondrial Ca²⁺ homeostasis in cell pathophysiology is widely accepted, the possibility that cAMP regulates mitochondrial functions has only recently received experimental support. The site of cAMP production, its targets, and its functions in the organelles remain uncertain. Using a variety of genetic/pharmacological tools, we here demonstrate that the mitochondrial inner membrane is impermeable to cytosolic cAMP, while an autonomous cAMP signaling toolkit is expressed in the matrix. We demonstrate that rises in matrix Ca²⁺ powerfully stimulate cAMP increases within mitochondria and that matrix cAMP levels regulate their ATP synthesizing efficiency. In cardiomyocyte cultures, mitochondrial cAMP can be increased by treatments that augment the frequency and amplitude of Ca²⁺ oscillations within the cytosol and organelles, revealing that mitochondria can integrate an oscillatory Ca²⁺ signal to increase cAMP in their matrix. The present data reveal the existence, within mitochondria, of a hitherto unknown crosstalk between Ca²⁺ and cAMP.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23747252     DOI: 10.1016/j.cmet.2013.05.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  81 in total

Review 1.  Pseudoscaffolds and anchoring proteins: the difference is in the details.

Authors:  Stacey Aggarwal-Howarth; John D Scott
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

Review 2.  Soluble adenylyl cyclase in health and disease.

Authors:  Andreas Schmid; Dimirela Meili; Matthias Salathe
Journal:  Biochim Biophys Acta       Date:  2014-07-23

Review 3.  Cyclic AMP synthesis and hydrolysis in the normal and failing heart.

Authors:  Aziz Guellich; Hind Mehel; Rodolphe Fischmeister
Journal:  Pflugers Arch       Date:  2014-04-24       Impact factor: 3.657

4.  Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate.

Authors:  Silke Kleinboelting; Ana Diaz; Sebastien Moniot; Joop van den Heuvel; Michael Weyand; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

Review 5.  The Pancreatic β-Cell: The Perfect Redox System.

Authors:  Petr Ježek; Blanka Holendová; Martin Jabůrek; Jan Tauber; Andrea Dlasková; Lydie Plecitá-Hlavatá
Journal:  Antioxidants (Basel)       Date:  2021-01-29

Review 6.  Interrogating cyclic AMP signaling using optical approaches.

Authors:  Jason Y Jiang; Jeffrey L Falcone; Silvana Curci; Aldebaran M Hofer
Journal:  Cell Calcium       Date:  2017-03-01       Impact factor: 6.817

7.  Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.

Authors:  Belén Mollá; Diana C Muñoz-Lasso; Pablo Calap; Angel Fernandez-Vilata; María de la Iglesia-Vaya; Federico V Pallardó; Maria Dolores Moltó; Francesc Palau; Pilar Gonzalez-Cabo
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 8.  New insights concerning the molecular basis for defective glucoregulation in soluble adenylyl cyclase knockout mice.

Authors:  George G Holz; Colin A Leech; Oleg G Chepurny
Journal:  Biochim Biophys Acta       Date:  2014-06-27

9.  Impact of atypical mitochondrial cyclic-AMP level in nephropathic cystinosis.

Authors:  Francesco Bellomo; Anna Signorile; Grazia Tamma; Marianna Ranieri; Francesco Emma; Domenico De Rasmo
Journal:  Cell Mol Life Sci       Date:  2018-03-16       Impact factor: 9.261

10.  Pharmacological distinction between soluble and transmembrane adenylyl cyclases.

Authors:  Jacob L Bitterman; Lavoisier Ramos-Espiritu; Ana Diaz; Lonny R Levin; Jochen Buck
Journal:  J Pharmacol Exp Ther       Date:  2013-10-03       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.